WIKLER MATTHEW reported 2 transactions at MATINAS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/24/2021ACC: 0000905718-21-000826
Director
Since Jun 2018
+14.39K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
14.40K acquired · 6.00 disposed
Non-Derivative Transactions2
Common Stock, par value $0.0001 per share
Direct
Shares
+2.40K
Price / share
—
Trade value
—
% of position
1.0%
6/19/2021
251.86K→254.26K
Common Stock, par value $0.0001 per share
Direct
Shares
+12K
Price / share
—
Trade value
—
% of position
4.7%
6/19/2021
254.26K→266.26K
Total
Net shares
+14.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 6/19/2021 | J · J | +2.40K | — | — | 1.0% | 251.86K | 254.26K |
| Common Stock, par value $0.0001 per share Direct | 6/19/2021 | C · Conversion | +12K | — | — | 4.7% | 254.26K | 266.26K |
| Total | +14.40K | $0.00 | ||||||
Derivative Transactions1
Series B Preferred Stock
Direct
Converts to
Common Stock
12K shares
Shares
−6.00
Strike price
0.5
Held after
0.00
Exercisable
—
6/19/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock12K shares | 6/19/2021 | C · Conversion | −6.00 | 0.5 | — | 0.00 |